Our Story

From breakthrough to global impact

What started as four scientists with a shared vision has evolved into a global force in genomic medicine. Our founders—Professors Peter Donnelly and Gil McVean, Dr Gerton Lunter and Dr Chris Spencer—began this journey in a single office above an Oxford pharmacy. A decade later, we're 140+ strong across the UK and US, with over 40% of our team holding PhDs. From that first breakthrough to today's global partnerships, we're accelerating the journey from genetic discovery to life-saving treatments—bringing precision medicine from the lab to the world.

Learn more
Group photo of Genomics founders—Professors Peter Donnelly and Gil McVean, Dr Gerton Lunter, and Dr Chris Spencer—standing together and smiling, representing the leadership behind the company’s genomic medicine mission.

We decode the language of life to unlock personalised health solutions.

We make the invisible, visible

We make the universal, personal

We make the theoretical, practical

We make the impossible, possible

Pioneering genomic innovation

Genomics is a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, bringing new understanding to both discovery and therapeutic development. At the University of Oxford, we're advancing the frontiers of genetic science.

Our proprietary algorithms and databases can accurately link genetic variation across human genomes to disease outcomes. We generate insights for healthcare systems, delivering preventative healthcare solutions that transform lives through early disease detection and intervention.

Scenic street view near the University of Oxford, featuring traditional British architecture and the iconic tower of the Oxford Oratory, representing Genomics’ academic roots.
Aerial view of Cambridge, UK, showing the blend of historic university buildings and green spaces, symbolising the research environment behind Genomics’ advancements in global health.

Advancing global health

Through Health & Wellness, we are leading the new area of genomic prevention—a paradigm-changing approach to personalised healthcare. Using advanced, reliable risk estimates for common diseases, we deliver targeted screening to prevent disease or catch it early when outcomes remain favorable.

Our population health management services and clinical decision support tools bring genetic insights to healthcare providers worldwide, ensuring personalized risk prediction reaches those who need it most.

Accelerating drug discovery

Through our Life Sciences division, we partner with leading pharmaceutical companies to incorporate deep genetic insights into drug research and development.Backed by one of the world's leading investors in life sciences, the Genomics team operates as a multi-disciplinary group of over 100 scientists, engineers and deployment specialists.

Our expertise in turning world-leading science into powerful applications continues to accelerate healthcare breakthroughs in Oxford, Amsterdam, Cambridge (UK), Cambridge (MA), and Boston (US).

A row of colorful sailboats docked on the Charles River with the Boston skyline in the background, highlighting Genomics' presence and collaboration in the United States.

Our investors

From Oxford to the world

What began with four visionaries at the University of Oxford has grown into a global force of over 140 experts. Our scientists, engineers, and innovators span three continents but share one mission: transforming how the world understands and uses genomics. From our labs in Oxford and Cambridge to our offices in Boston, we're building bridges between cutting-edge research and real-world healthcare solutions. This is precision medicine without borders—powered by diverse perspectives, united by purpose.

Meet the team
Professor Peter Donnelly, co-founder of Genomics, drawing on a whiteboard inside a modern lab—capturing the scientific vision and leadership behind the company’s global genomic mission.